Similar articles

• Use of pressors in the management of septic shock.

  Keddissi JI, Bright BC, Dernaika TA. Keddissi JI, et al. Lancet. 2007 Dec 1;370(9602):1827; author reply 1827-8. doi: 10.1016/S0140-6736(07)61772-3. Lancet. 2007. PMID: 18061056 No abstract available.
• Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

  Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E; CATS Study Group. Annane D, et al. Lancet. 2007 Aug 25;370(9588):676-84. doi: 10.1016/S0140-6736(07)61344-0. Lancet. 2007. PMID: 17720019 Clinical Trial.
• Inotrope and vasopressor therapy of septic shock.

  Hollenberg SM. Hollenberg SM. Crit Care Clin. 2009 Oct;25(4):781-802, ix. doi: 10.1016/j.ccc.2009.07.003. Crit Care Clin. 2009. PMID: 19892253 Review.
• Catecholamine treatment for shock--equally good or bad?

  Singer M. Singer M. Lancet. 2007 Aug 25;370(9588):636-7. doi: 10.1016/S0140-6736(07)61317-8. Lancet. 2007. PMID: 17719998 No abstract available.
• Current therapy of shock.

  Goldberg LI, Talley RC. Goldberg LI, et al. Adv Intern Med. 1971;17:363-78. Adv Intern Med. 1971. PMID: 4147306 Review. No abstract available.